Clinical trial
A Study of DPC 817 in HIV-Infected Males
NCT00040274 · Pharmasset, Industry · Completed
Key facts
| NCT number | NCT00040274 |
|---|---|
| Title | A Study of DPC 817 in HIV-Infected Males |
| Official title | A Placebo-Controlled, Dose-Escalation Study in HIV-1 Infected Subjects to Characterize the Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of DPC 817 |
| Lead sponsor | Pharmasset, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | DPC 817 |
| Enrollment | 30 |
| First posted | Jun 25, 2002 |
| Last update posted | Jul 19, 2005 |
| Countries | Germany, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: